Identification of viral exposure signatures for early detection of liver cancer
Identification of viral exposure signatures for early detection of liver cancer
批准号:
10487275
负责人:
Xin Wei Wang
金额:
$17.01万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AffectCCRChronic DiseaseCommunitiesData AnalysesDevelopmentEmerging TechnologiesEpitopesExtramural ActivitiesHealthHumanHuman ResourcesImmunityIndividualInfectionLeadershipMalignant NeoplasmsMethodologyMolecularPathogenesisPathogenicityProceduresResearch PersonnelScreening for Hepatocellular CancerSerologyServicesTechnologyViralVirusdata acquisitiondata pipelinehuman viromeresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Viruses are known to affect human health by altering host immunity and leaving a unique molecular footprint during infection, which makes the interplay between the human virome and the host a crucial molecular window reflecting the pathogenesis of human chronic diseases including cancer. The CCR Human Virome Core has successfully developed and implemented a standard operating procedure, including a pipeline from data acquisition to data analysis, for an emerging technology called VirScan. This technology allows comprehensive profiling of individuals' serological responses to all known human viruses including over 200 species and 1,000 strains of human pathogenic and non-pathogenic viruses at the epitope level. Currently, efforts are aimed at establishing the core, including hiring personnel.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10262066
-
项目类别:
-
资助金额:$190.21万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10702767
-
项目类别:
-
资助金额:$25.47万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Roles of microbiota-mediated hepatocarcinogenesis
-
批准号:10925957
-
项目类别:
-
资助金额:$57.3万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10702334
-
项目类别:
-
资助金额:$200.12万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10926086
-
项目类别:
-
资助金额:$28.65万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Mechanism of viral hepatitis-mediated hepatocarcinogenesis
-
批准号:10262018
-
项目类别:
-
资助金额:$17.29万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10262174
-
项目类别:
-
资助金额:$34.58万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10262173
-
项目类别:
-
资助金额:$34.58万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Roles of microbiota-mediated hepatocarcinogenesis
-
批准号:10702289
-
项目类别:
-
资助金额:$25.47万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Identification of viral exposure signatures for early detection of liver cancer
-
批准号:10703084
-
项目类别:
-
资助金额:$18.19万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10262566
-
项目类别:
-
资助金额:$69.17万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The identification of human hepatocellular carcinoma metastasis genes
-
批准号:10702428
-
项目类别:
-
资助金额:$47.3万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Molecular signatures for liver cancer diagnosis and treatment stratification
-
批准号:10925998
-
项目类别:
-
资助金额:$114.6万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10926085
-
项目类别:
-
资助金额:$85.95万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
The role of cancer stem cells in liver cancer heterogeneity and subtypes
-
批准号:10702427
-
项目类别:
-
资助金额:$47.3万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
Viral exposure signatures may define individuals vulnerable for COVID-19
-
批准号:10487079
-
项目类别:
-
资助金额:$23.81万
-
财政年份:--
-
负责人:Xin Wei Wang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CCL20/CCR6/SEMA3C信号轴通过EMT及肿瘤干细胞互作调控阴茎癌转移的分子机制研究
-
批准号:2026JJ50313
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡希恒
-
依托单位:
复杂碳源下地衣芽孢杆菌乳糖操纵子多层级调控机制解析及抗CCR表达系统文库理性构建
-
批准号:2026JJ70080
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李思宇
-
依托单位:
基于Hippo-YAP信号通路介导的CCR2-巨噬细胞增殖探讨血府逐瘀汤干预冠心病小鼠的作用机制
-
批准号:2026JJ82177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:崔君俊
-
依托单位:
基于“肠肺同治”探讨厚朴通过菌群-SCFAs-CCR9/α4β7轴调控Tregs归巢缓解溃疡性结肠炎的作用机制
-
批准号:2026JJ80497
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李芳
-
依托单位:
PCED1B-AS1/let-7a-5p/CCR7轴调控口腔癌淋巴结转移的分子机制研究
-
批准号:2026JJ82576
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:薛蕾
-
依托单位:
CCR2+巨噬细胞通过GDF15-TGRBR2活化成纤维细胞驱动OSF发生 的机制研究
-
批准号:2026JJ50569
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:戴小寒
-
依托单位:
CCR2工程化仿生纳米药物驱动胶质母细胞瘤放疗增敏与免疫逆转研究
-
批准号:2026JJ60064
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郝欣岩
-
依托单位:
PURB/CCR9/ERM信号通路在T-ALL耐药中的作用机制研究
-
批准号:JCZRLH202601966
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
IL-17/CCL3/CCR5介导星形胶质细胞与小胶质细胞相互作用在心脏骤停致 神经炎症反应中的作用机制研究
-
批准号:2026JJ50568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邹联洪
-
依托单位:
CCR9调控Treg向低免疫抑制功能极化在T1D致病中的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:夏玉莲
-
依托单位: